Redsense Medical presents at Sedermeradagen Stockholm 2024

Sedermera Corporate Finance will once again host Sedermeradagen on May 22, 2024. The event will take place at Hotel At Six in Stockholm and offers the opportunity to get to know 16 highly interesting growth companies.

Redsense Medical CEO Pontus Nobréus will present the company. The presentation will be held in Swedish. To register and for more information about the event: Sedermeradagen Stockholm 2024 - Sedermera Corporate Finance

Contact information

For more information, please contact: 
Pontus Nobréus, CEO
Telephone: +46 72-171 1264
E-mail: pontus.nobreus (at) redsensemedical.com

Redsense Medical AB (publ), 556646-4862

ABOUT REDSENSE MEDICAL

Redsense Medical is a corporate group with operations mainly in Europe and the United States. The company has developed the Redsense System, an innovation used for monitoring and alarm in the case of blood leakage in connection with a hemodialysis treatment. Redsense Medical solves one of the most serious remaining safety problems within hemodialysis – to quickly detect Venous Needle Dislodgement and catheter leakage to minimize blood leakage. The system consists of a patented fiber optic sensor, designed for either venous needle or central venous catheter, which is connected to an alarm unit. From the very start, the development of the company's technology has been based on the demands and safety requirements of healthcare providers in the dialysis sector. The Redsense Medical share is listed on Spotlight Stock Market (REDS) and traded on OTCQX (RDSNF) in the US.